The VITALITY study has achieved it's one-year participant follow up visit milestone on where we had the first participants recruited in VITALITY completing their week 48 of taking the trial drugs across the two sites (Zimbabwe and Zambia). This is a big achievement for the study as week 48 visit determines the primary outcome of the study. The Zimbabwe team had their first week 48 visits on 6 January 2022 whilst, Zambia had their first week 48 visits on 31 January 2022. The VITALITY study is also celebrating another huge milestone. The protocol paper has now been published in the BMC trials journal. Link to full text article https://rdcu.be/cFM7Y
mufaronashe
Comments